-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U8a1ypidwRXxhuj4P0+Yc64irCS29D2HdMAV2Kn5pTW9DHzTVU4r85QZu2LcLn1e KwCAFOPGGBastECisYevlQ== 0001225208-10-018360.txt : 20100804 0001225208-10-018360.hdr.sgml : 20100804 20100804160738 ACCESSION NUMBER: 0001225208-10-018360 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100804 FILED AS OF DATE: 20100804 DATE AS OF CHANGE: 20100804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dockendorff Charles J CENTRAL INDEX KEY: 0001400563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33259 FILM NUMBER: 10991104 MAIL ADDRESS: STREET 1: COVIDIEN LTD. STREET 2: 15 HAMPSHIRE STREET CITY: MANSFIELD STATE: MA ZIP: 02048 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Covidien plc CENTRAL INDEX KEY: 0001385187 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 980624794 FISCAL YEAR END: 0924 BUSINESS ADDRESS: STREET 1: CHERRYWOOD BUSINESS PARK STREET 2: BLOCK G, FIRST FLOOR CITY: LOUGHLINSTOWN STATE: L2 ZIP: DUBLIN 18 BUSINESS PHONE: 353 1 439-3000 MAIL ADDRESS: STREET 1: CHERRYWOOD BUSINESS PARK STREET 2: BLOCK G, FIRST FLOOR CITY: LOUGHLINSTOWN STATE: L2 ZIP: DUBLIN 18 FORMER COMPANY: FORMER CONFORMED NAME: Covidien Ltd. DATE OF NAME CHANGE: 20070321 FORMER COMPANY: FORMER CONFORMED NAME: Tyco Healthcare Ltd. DATE OF NAME CHANGE: 20070104 4 1 doc4.xml X0303 4 2010-08-04 0001385187 Covidien plc COV 0001400563 Dockendorff Charles J C/O COVIDIEN 15 HAMPSHIRE STREET MANSFIELD MA 02048 1 EVP & Chief Financial Officer Ordinary Shares 2010-08-04 4 P 0 5500 37.2387 A 98339 D The price reported is a weighted average price. Shares were sold in multiple transactions at prices ranging from $37.2375 and $37.2400. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a securityholder of the Issuer, full information regarding the number of shares sold at each separate price. By: John W. Kapples, Attorney in Fact 2010-08-04 -----END PRIVACY-ENHANCED MESSAGE-----